Literature DB >> 30138243

Minimally Invasive Versus Full-Sternotomy Septal Myectomy for Hypertrophic Cardiomyopathy.

Farah N Musharbash, Matthew R Schill, Vivek H Hansalia, Richard B Schuessler, Jeremy E Leidenfrost1, Spencer J Melby, Ralph J Damiano.   

Abstract

OBJECTIVE: Septal myectomy remains the criterion standard for the treatment of patients with hypertrophic obstructive cardiomyopathy refractory to medical therapy. There have been few reports of minimally invasive approaches. This study compared a minimally invasive septal myectomy performed at our institution with the traditional full-sternotomy approach.
METHODS: Patients receiving a stand-alone septal myectomy were retrospectively reviewed from November 1999 to December 2016 (N = 120). Patients were stratified by surgical approach: traditional full sternotomy (n = 34) and ministernotomy (n = 86). Preoperative and perioperative variables were compared as well as follow-up symptomatic and echocardiographic outcomes.
RESULTS: Both groups had a significant decrease in New York Heart Association class heart failure symptoms (P < 0.001). At a mean ± SD follow-up time of 2.0 ± 3.4 years, postoperative New York Heart Association class distribution was similar between ministernotomy and full sternotomy (P = 0.684). Follow-up resting left ventricular outflow tract gradient was also similar between ministernotomy and full sternotomy (11 mm Hg ± 15 vs 9 mm Hg ± 13, P = 0.381). Perioperatively, ministernotomy was not significantly different from full sternotomy in median cardiopulmonary bypass time (81 minutes vs 78 minutes, P = 0.101) but had a slightly longer median cross-clamp time (39 minutes vs 35 minutes, P = 0.017). Major complications were similar in the two groups. There was one 30-day mortality in the full-sternotomy group, but no in-hospital deaths.
CONCLUSIONS: Septal myectomy performed using a minimally invasive approach has similar outcomes to the criterion standard operation done through a full sternotomy. It represents a feasible option for patients with hypertrophic obstructive cardiomyopathy unresponsive to medications.

Entities:  

Mesh:

Year:  2018        PMID: 30138243      PMCID: PMC6115297          DOI: 10.1097/IMI.0000000000000536

Source DB:  PubMed          Journal:  Innovations (Phila)        ISSN: 1556-9845


  27 in total

Review 1.  American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.

Authors:  Barry J Maron; William J McKenna; Gordon K Danielson; Lukas J Kappenberger; Horst J Kuhn; Christine E Seidman; Pravin M Shah; William H Spencer; Paolo Spirito; Folkert J Ten Cate; E Douglas Wigle
Journal:  J Am Coll Cardiol       Date:  2003-11-05       Impact factor: 24.094

2.  Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy.

Authors:  Shikhar Agarwal; E Murat Tuzcu; Milind Y Desai; Nicholas Smedira; Harry M Lever; Bruce W Lytle; Samir R Kapadia
Journal:  J Am Coll Cardiol       Date:  2010-02-23       Impact factor: 24.094

Review 3.  Hypertrophic cardiomyopathy.

Authors:  Barry J Maron; Martin S Maron
Journal:  Lancet       Date:  2012-08-06       Impact factor: 79.321

4.  Operative treatment in idiopathic hypertrophic subaortic stenosis. Techniques, and the results of preoperative and postoperative clinical and hemodynamic assessments.

Authors:  A G Morrow; T J Fogarty; H Hannah; E Braunwald
Journal:  Circulation       Date:  1968-04       Impact factor: 29.690

5.  Impact of minimally invasive valvular heart surgery: a case-control study.

Authors:  E A Grossi; A C Galloway; G H Ribakove; P K Zakow; C C Derivaux; F G Baumann; D Schwesinger; S B Colvin
Journal:  Ann Thorac Surg       Date:  2001-03       Impact factor: 4.330

6.  Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis.

Authors:  Mahboob Alam; Hisham Dokainish; Nasser M Lakkis
Journal:  Eur Heart J       Date:  2009-02-19       Impact factor: 29.983

7.  Hypertrophic subaortic stenosis. Operative methods utilized to relieve left ventricular outflow obstruction.

Authors:  A G Morrow
Journal:  J Thorac Cardiovasc Surg       Date:  1978-10       Impact factor: 5.209

8.  A Novel Minimally Invasive Approach for Surgical Septal Myectomy.

Authors:  Amine Mazine; Aly Ghoneim; Ismail Bouhout; William Fortin; Ilyes Berania; Philippe L L'Allier; Patrick Garceau; Denis Bouchard
Journal:  Can J Cardiol       Date:  2016-04-07       Impact factor: 5.223

9.  Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; Iacopo Olivotto; Sandro Betocchi; Susan A Casey; John R Lesser; Maria A Losi; Franco Cecchi; Barry J Maron
Journal:  N Engl J Med       Date:  2003-01-23       Impact factor: 91.245

10.  The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms.

Authors:  Camillo Autore; Paola Bernabò; Caterina Stella Barillà; Paolo Bruzzi; Paolo Spirito
Journal:  J Am Coll Cardiol       Date:  2005-04-05       Impact factor: 24.094

View more
  1 in total

Review 1.  Review of Contemporary Invasive Treatment Approaches and Critical Appraisal of Guidelines on Hypertrophic Obstructive Cardiomyopathy: State-of-the-Art Review.

Authors:  Steven Lebowitz; Mariusz Kowalewski; Giuseppe Maria Raffa; Danny Chu; Matteo Greco; Caterina Gandolfo; Carmelo Mignosa; Roberto Lorusso; Piotr Suwalski; Michele Pilato
Journal:  J Clin Med       Date:  2022-06-14       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.